Shanghai INT Medical Instruments Co., Ltd. engages in the research and development, manufacturing, and sales of interventional and implantable medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 2,007 full-time employees. The company went IPO on 2019-11-08. The firm operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The firm mainly operates its businesses in the domestic market and overseas markets.
01501.HK stock price ended at $31.18 on 星期五, after rising 0.91%
On the latest trading day Jan 16, 2026, the stock price of 01501.HK rose by 0.91%, climbing from $31.00 to $31.18. Throughout the session, the stock experienced a volatility of 0.71%, with prices fluctuating between a daily low of $30.98 and a high of $31.20. Alongside this price increase, trading volume also rose by 42.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 50.8K shares were traded, amounting to a market value of approximately $3.1B.